article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

article thumbnail

Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling

Bill Of Health

Attorney Gene Quinn offers the most dramatic interpretation, calling the Supreme Court’s embrace of full scope enablement in Amgen “a cataclysmic shift in the law of enablement,” not just for antibodies but for “the life sciences community and beyond.” Amgen’s significance has often been overstated. It was formally repealed in 2018.)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hong Kong Exchange: Nurturing China’s Biotech Valley

Health Advances

Investors in Hong Kong who are closer to China can better understand the equity story of Chinese biotechnology companies. Following Hong Kong’s steps, Shanghai’s Science and Technology Innovation Market (STAR) changed its criteria to allow pre-revenue biotechs to list in May. explains Chen.

article thumbnail

Athos Therapeutics Taps Vultr Cloud GPU to Power AI Drug Discovery Engine

HIT Consultant

Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. This choice ensures compliance with data sovereignty and privacy regulations, crucial for handling sensitive AI training data.